Offerings // Emmaus Life Sciences, Inc.

EMMA offering history

Every offering-related filing in Emmaus Life Sciences, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 1,003 filings back to Sep 2, 2009.

Last executed offering
Dec 22, 2025
8-K — priced deal (shares or notes)
Last registration (announced)
Dec 14, 2018
S-1 — capacity, not a sale
Executed, last 12 months
1
424B pricings + 8-K 3.02 sales
Registered, last 12 months
0
S-1/S-3/F-series registrations
DateFilingWhat it means
Dec 22, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Feb 26, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Dec 20, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Mar 7, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jan 19, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Feb 16, 20218-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Mar 3, 2020424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 25, 2019424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 14, 2019424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jun 11, 2019EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
May 24, 2019424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 26, 2018424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 21, 2018EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 14, 2018S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Sep 26, 20188-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jun 29, 2018EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jun 8, 2018S-3/A →REGISTEREDS-3/A registration — capacity to sell shares, not a sale yet
Jun 8, 2018424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jun 8, 2018EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jun 8, 2018EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
May 22, 2018S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
May 18, 2018RW →WITHDRAWNRegistration withdrawn
May 18, 2018S-3/A →REGISTEREDS-3/A registration — capacity to sell shares, not a sale yet
May 18, 20188-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
May 18, 2018S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Apr 3, 20188-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Feb 23, 2018S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Feb 23, 2018S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Jul 17, 2017424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Jul 13, 2017S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jul 13, 2017FWP →MARKETINGFree-writing prospectus — offering being marketed
Jul 13, 2017EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 3, 2017FWP →MARKETINGFree-writing prospectus — offering being marketed
Jun 30, 2017S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jun 19, 2017FWP →MARKETINGFree-writing prospectus — offering being marketed
Jun 16, 2017S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jun 2, 2017S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Mar 31, 2017S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Mar 24, 20178-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Feb 16, 2017424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
EMMA offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full EMMA workspace →
EMMA offering FAQ

When did EMMA last execute an offering?

Per SEC filings, Emmaus Life Sciences, Inc.'s most recent priced offering document is a 8-K filed 2025-12-22. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did EMMA last announce or register an offering?

The most recent registration is a S-1 filed 2018-12-14. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.